The 14th Annual Pharmaceutical IT Congress promised an in-depth look into the future innovations of technology in the life sciences industry, and I have to say, London did not disappoint.
On September 28-29, I joined over 150 pharmaceutical information technology and business specialists as we dove into key topics that are currently top of mind for the industry. Our main focus was on IT's role in the digital transformation journey; including:
- Technology to create new pathways and channels to engage patients.
- Approaches to manage clinical trials more effectively to accelerate time to market, and
- How big data and data analytics can be harnessed to improve patient-centric approaches.
We also considered the current challenges impeding Pharma innovation; such as, disparate systems that make information difficult to synthesize, and the lack of strong data governance and process controls in outdated technology.
My joint presentation with Sanofi touched on many of these issues and areas of interest, sparking a lot of engaging conversations.
After speaking with leaders in the pharmaceutical industry, it is very clear to me that digital transformation isn't something that can be implemented in the distant future, it is a very real need today. Life science companies are buckling under the weight of ever-growing regulations and are getting lost in a maze of scattered data. Legacy systems are hurting, more than helping their business processes, ultimately endangering their relationships and reputations.
Luckily, the shift toward digital transformation in the pharmaceutical industry has already begun. You can see how Appian is helping one of the leading pharma companies achieve innovation in this use case.
If you would like to discuss these topics further, or have any questions, please feel free to contact me at evi.cohen@appian.com.
Evi Cohen
Life Sciences Global Practice Leader
